Insights

Pharmaceuticals and Life Sciences Pharmaceuticals and Life Sciences

Type (0)

Results

All Insights

Osler Update September 1, 2016

Emergency situations: The hospital is prepared, but are your critical suppliers?

Hospitals that adopt standard, unqualified force majeure clauses in their services contracts do so at their own peril. Learn more.

Read more
Osler Update June 7, 2016

Federal Court continues to breathe life into motions to dismiss proceedings under the Patented Medicines (Notice of Compliance) Regulations

In amended reasons released on May 26, 2016, the Federal Court in Janssen Inc. v. Celltrion Healthcare Co. Ltd. granted a motion to dismiss an...

Read more
Osler Update June 6, 2016

$125-million pharmaceutical damages award undone by hearsay rule

The Court questioned Teva’s ability to supply the market due to its reliance on inadmissible hearsay evidence. The judgment is expected to have...

Read more
Osler Update January 25, 2016

Drug Licensees Subject To Federal Price Regulation In Canada – Law360

Canada has long regulated the price of patented pharmaceutical products with the intent to protect consumers from excessive prices. In recent years,...

Read more